Recently approved Drugs

  • Resmetirom is a selective thyroid hormone receptor-beta (THR-β) agonist. It targets liver cells to reduce fat accumulation and inflammation

Recently approved for Noncirrhotic NASH and moderste to advanced lover fibrosis

Dosage;
<100kg: 80mg

100kg: 100mg

3 Likes

Recently, FDA has given approval for conducting trials on Bisoprolol for anti hypertensive activity

3 Likes